Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Me, once valued at $6 billion, is now a penny stock. Layoffs, data breaches, and resignations led to its downfall. How did it ...

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...

The recent release of the latest BioRegion Report brought with it some very welcome news for Catalonia, as the autonomous northeastern region of Spain consolidated its place as one of the country’s ...